Literature DB >> 6217254

Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.

M Malkovský, G L Asherson, P Chandler, V Colizzi, M C Watkins, M Zembala.   

Abstract

Lyt-1+2+ hapten-specific T suppressor cells (Ts) from mice injected and then painted with picryl or oxazolone derivatives produce hapten-specific T suppressor factors (TsF) in vitro. Stimulation by painting with contact sensitizer (which need not be specific) gives rise to Lyt-1-2+, I-J+, cyclophosphamide-sensitive T acceptor cells (Tacc). When the Tacc population is armed with TsF and then is exposed to specific antigen in the context of I-J-controlled determinants (antigen-presenting, haptenized spleen cells and Ts sharing the same I-J subregion), a nonspecific inhibitor of DNA synthesis (nsINH) appears in the supernatant. This inhibitor suppresses the primary DNA synthetic response to concanavalin A, lipopolysaccharide, and alloantigens in both syngeneic and allogeneic lymphocytes. The nsINH is only effective when added to lymphocyte cultures less than 8 hr after the stimulation with concanavalin A. The nsINH, however, affects neither primary nor secondary cytotoxicity in vitro. These data suggest the mouse immune system is capable of selective regulation of the response to specific antigen by the production of nonspecific soluble suppressor factor(s).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor.

Authors:  D W Horohov; J H Wyckoff; R N Moore; B T Rouse
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 2.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

3.  Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis.

Authors:  R Blackstock; N C Hernandez
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 4.  Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.

Authors:  J C Reed; P C Nowell
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Induction of suppressor cells by staphylococcal enterotoxin B: identification of a suppressor cell circuit in the generation of suppressor-effector cells.

Authors:  M Holly; Y S Lin; T J Rogers
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  Non-specific inhibitor made by T acceptor cells inhibits both the afferent and efferent stage of the contact sensitivity reaction.

Authors:  M A Zembala; V Colizzi; G L Asherson; M C Watkins
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

7.  T helper factor in contact sensitivity: antigen-specific I-A+ helper factor is made by an Lyt-1+2-, I-A+, I-J- T cell.

Authors:  V Colizzi; G L Asherson; B M James; M Malkovsky
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

8.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Effect of ASTA Z 7557 (INN mafosfamide) a precursor of 4-hydroxy-cyclophosphamide on human T-lymphocytes' Fc-receptors and immunoregulatory functions.

Authors:  J G Saal; M Hadam; F Frank; H Rautenstrauch; P Fritz
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.